This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Immune Thrombocytopenia (ITP) Immune-Genetic Assessment (UNIT)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2010 by Azienda Sanitaria-Universitaria Integrata di Udine.
Recruitment status was:  Not yet recruiting
Sponsor:
Information provided by:
Azienda Sanitaria-Universitaria Integrata di Udine
ClinicalTrials.gov Identifier:
NCT01196884
First received: September 7, 2010
Last updated: September 8, 2010
Last verified: September 2010
September 7, 2010
September 8, 2010
September 2010
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Immune Thrombocytopenia (ITP) Immune-Genetic Assessment
IMMUNE-GENETIC ASSESSMENT OF PRIMARY ITP IN ADULT

Primary ITP has wide heterogenous biology, presentation and response to therapy.

The immune-genetic assessment of ITP may help to identify differences among patients with ITP and optimize the therapeutic choice.

Not Provided
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample
Primary care clinic
Thrombocytopenia
Not Provided
  • Asymptomatic ITP patients
  • ITP patients treated with Rituximab
  • ITP patients treated with steroids
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
190
Not Provided
Not Provided

Inclusion Criteria:

  • Adult patients with primary ITP

Exclusion Criteria:

  • Secondary ITP
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
Italy
 
 
NCT01196884
UNIT
Not Provided
Not Provided
Not Provided
Not Provided
Francesco Zaja, Clinica Ematologica, Azienda Ospedaliero Universitaria S. Maria Misericordia di Udine
Azienda Sanitaria-Universitaria Integrata di Udine
Not Provided
Not Provided
Azienda Sanitaria-Universitaria Integrata di Udine
September 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP